We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Microbes Identified, Linked to Severe Diarrhea

By LabMedica International staff writers
Posted on 09 Jul 2014
Print article
454 Life Sciences Genome Sequencer FLX system
454 Life Sciences Genome Sequencer (Photo courtesy of Roche Diagnostics)
Microorganisms have been identified that may trigger diarrheal disease and others that may protect against it, which were not widely linked to the condition previously.

Diarrheal diseases continue to contribute significantly to morbidity and mortality in infants and young children in developing countries and there is an urgent need to better understand the contributions of novel, potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut microbiota composition that might facilitate severe disease.

An international team of scientists led by those at the University of Maryland (College Park, MD, USA) surveyed the intestinal microbiota of 992 children from four under-developed countries in West Africa (The Gambia and Mali), East Africa (Kenya), and South Asia (Bangladesh). Stool samples were selected from a large case/control study of moderate-to-severe diarrhea in children aged less than five years. All samples were analyzed by traditional microbiological tests for known bacterial, viral, and eukaryotic pathogens.

DNA was isolated and extracted using the QIAamp DNA stool extraction kit (Qiagen; Venlo, The Netherlands). DNA was amplified using “universal” primers targeting the V1-V2 region of the 16S ribosomal ribonucleic acid (rRNA) gene, a small subunit of the ribosome, in bacteria. Both forward and reverse primers had a 5’ portion specific for use with FLX sequencing technology (454 Life Sciences; Branford, CT, USA).

The scientists identified statistically significant disease associations with several organisms already implicated in diarrheal disease, such as members of the Escherichia/Shigella genus and Campylobacter jejuni. They also found that organisms not widely believed to cause the disease, including Streptococcus and Granulicatella, correlated with the condition in their study. In addition, the study revealed that the Prevotella genus and Lactobacillus ruminis may play a protective role against diarrhea. In almost 50% of the children examined with diarrhea, the condition could not be attributed to a specific causal pathogen. The team also found numerous children carrying Shigella, which is known to cause problems, yet the children showed no signs of moderate to severe diarrhea.

The authors concluded that their analysis of the 16S rRNA gene-based taxonomic profile of diarrheal and control stool samples demonstrated a strong association between acute diarrheal disease and the overall taxonomic composition of the stool microbiota in young children from the developing world. O. Colin Stine, PhD, a professor and senior author of the study said, “We were able to identify interactions between microbiota that were not previously observed, and we think that some of those interactions may actually help prevent the onset of severe diarrhea.” The study was published on June 27, 2014, in the journal Genome Biology.

Related Links:

University of Maryland
454 Life Sciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more